https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/08/US_BO_EHA26-visual-summaries_V05_MRC-approved.pdf 2026-08-26T23:44:32+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/08/MANGROVE-Study-Design.pdf 2026-08-24T09:38:09+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Stilgenbauer_EHA2026_CDAC-101_RR_CLL_Oral_FINAL.pdf 2026-06-15T08:29:09+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/BGB-11417-101-SZ-Update-TN-CLL_Cheah_EncOral_EHA_Final.pdf 2026-06-15T08:20:47+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Mocanu_EHA_2026_CDAC_101_CLL_FINAL.pdf 2026-06-11T06:03:45+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Trotman_EHA_2026_CDAC_101_WM_Poster_Final-1.pdf 2026-06-11T06:02:07+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Tariq_EHA-2026-CDAC-105-MM-CYP3A-DDI_Poster_Final-1.pdf 2026-06-11T05:59:47+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Opat_EHA2026_Sonro-101-SZ-RR-CLL_Poster_Final.pdf 2026-06-11T05:58:03+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Soumerai_EHA2026_Sonro_101_RR_MCL_Poster_Final.pdf 2026-06-11T05:56:23+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Song_EHA-2026_BGB-11417-201_China_Poster_APPROVAL-FOR-PRINT.pdf 2026-06-11T05:54:29+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/BGB-A317-210_TIRHOL-LYSA-Phase-2_Ghesquie%E2%95%A0Cres_poster_EHA_uploaded.pdf 2026-06-11T05:52:47+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Tedeschi_EHA2026-SEQUOIA-Elderly-Poster_FINAL.pdf 2026-06-11T05:50:55+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Tam_EHA2026_Zanu_SEQUOIA_PFS2_Encore_FINAL.pdf 2026-06-11T05:48:57+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Munir_EHA-2026-Zanu-HEOR-G-Z-v-VI-MAIC-TN-CLL-CLL17.pdf 2026-06-11T05:47:09+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA_ALPINE-Profile-Analysis_Poster_D3_29May2026.pdf 2026-06-11T05:44:38+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA_ALPINE-Impaired-HRQoL_Poster_D2_19May2026.pdf 2026-06-11T05:42:36+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA-2026_Integra-BTKi-CLL-Switch-Poster_v3_For-UPLOAD.pdf 2026-06-11T05:40:33+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA26_RWE-WM-Symphony_Poster_FINAL_for-UPLOAD.pdf 2026-06-11T05:37:54+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA26_Z-vs-A-TN-CLL_Poster_FINAL_for-UPLOAD.pdf 2026-06-11T05:35:37+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA-2026-Z-vs-A-Comp-Effect-CLL-Komodo-Poster_final.pdf 2026-06-11T05:32:51+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA-2026-Z-vs-A-Comp-Effect-MCL-Komodo-Poster_final.pdf 2026-06-11T05:30:10+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Ermann_EHA-2026-Zanu-HEOR-G-Lines-of-Therapy-Elderly.pdf 2026-06-11T05:27:50+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/HEOR_Zanu_Z-vs-A-Comp-Effect-MCL-Integra_Hou_Poster_EHA_uploaded.pdf 2026-06-11T05:24:51+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/EHA-2026-RW-AFib-Symphony-Poster_134x90_v05_encore.pdf 2026-06-11T05:20:38+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/ASCO-B7-H4-oral-presentation_FINAL_for-BOMA.pdf 2026-06-02T11:51:35+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/ASCO-2026-GPC3x4-1BB_Rapid-Oral_FINAL_for-BOMA.pdf 2026-06-02T11:47:49+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/ASCO-2026-HERIZON-GEA-01-PD-L1-Analysis_FINAL-for-BOMA.pdf 2026-06-01T21:25:08+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/HEOR_Zanu-Z-v-A-Comp-Effect-MCL-Komodo_Wang_Poster_ASCO_Final.pdf 2026-06-01T11:05:10+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/HEOR_Zanu-Z-v-A-Comp-Effect-CLL-Komodo_Jacobs_Poster_ASCO_Final.pdf 2026-06-01T11:02:31+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/HEOR_Zanu-RW-Impact-AFib-CLL-Symphony_Fradley_Poster_ASCO_Final.pdf 2026-06-01T11:00:15+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/HEOR_Zanu-Medicare-FFS-CE_Ermann_Poster_ASCO_Final.pdf 2026-06-01T10:58:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Alencar_ASCO2026-Sonro-RWE-Burden-Tx-Patterns_Poster_Updated.pdf 2026-06-01T10:56:13+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/Zanu_SEQUOIA_304_PFS2_CLL_ASCO_Final.pdf 2026-06-01T10:53:48+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/BGB-11417-304-TiP_Shadman_Poster_ASCO_Final.pdf 2026-06-01T10:51:42+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/BGB-11417-101_SZ-TN-CLL-w-del17p_Tam_Poster_ASCO_Final.pdf 2026-06-01T10:47:50+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/06/BGB-43395-101_Ph-1-first-disclosure_Goel_Poster_ASCO_Final.pdf 2026-06-01T10:45:42+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASCO-2026_315-EFS-by-Surg-Relevant-Subgroups_Poster_Final.pdf 2026-05-31T12:07:42+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-A317-305-Q-TWiST_Mehta_Poster_ASCO_Final.pdf 2026-05-30T16:57:22+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-A317-A3055-101-CCR8_Raimbourg_Poster_ASCO_Final.pdf 2026-05-30T16:54:31+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BG-C9074-101_B7-H4-TBW-to-AiBW_Giovinazzo_Poster_ASCO_Final.pdf 2026-05-30T16:50:34+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_ABSTRACT_incidence-of-cardiac-related-deaths-65-years-and-older-with-b-cell-malignancies-treated-with-ibrutinib.pdf 2026-05-21T17:59:23+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BeOne-EHA2025-Satellite-Symposium_Showfile.pdf 2026-05-21T12:41:58+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASCO-GI-2026-HERIZON-GEA-301-Oral-Presentation.pdf 2026-05-21T09:33:30+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-103_all.pdf 2026-05-19T17:36:19+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101_all.pdf 2026-05-19T17:03:09+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/CaDAnCe-101_all.pdf 2026-05-19T17:01:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Shadman_Zanu_304-ArmC_EHA-2025_Poster-final.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/SEQUOIA.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/iwCLL-25-NNH-Zanu-vs-Ibru-ALPINE-Poster_for-upload.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Safety-Z-vs-VO-infections_Lamanna_EncPoster_EHA_Final.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Scarfo_EHA2025_CDAC-101_RR_CLL_oral_v4.3_13Jun2025.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Tedeschi_iwCLL-2025_Zanu-304-Elderly-Poster-Final.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/iwCLL-25-Zanu-vs-AV-MAIC-Encore-Poster_for-upload.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Shadman_Zanu_304-ArmD_EHA-2025_Poster-final.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/iwCLL-25-Zanu-vs-AV-NMA-Encore-Poster_for-upload.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Shadman_iwCLL-2025_Zanu-Arm-C-Poster-Final.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Shadman_iwCLL-2025_Zanu-304-Arm-D-Poster-Final.pdf 2026-05-15T15:07:02+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ROSEWOOD.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-305-Biomarker_Qiu_Poster_AACR_Final.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/MAGNOLIA.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-305.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-302.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-43395-101.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-315.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Frustaci_EHA2025_CDAC-101_WM_oral_v4.1_11June2025-1.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-312.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-3111-215.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Cheah_EHA2025_sonro-101-SZ_RR-CLL_Oral_v4.1_13June2025.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/GS4748_292619-L3-2250-CR04_BeOne-ESMO-305-CAP-Poster-145x115cm-S08_PRINT-cropsbleed.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ESMO-2025_Poster_HPK1-1G_PRINT-READY.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/CELESTIAL-TN-CLL.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RWE-BTKi-Age-related-dis-CLL-Symphony_Yang_Poster_EHA_Final.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-303.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-304.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/CaDAnCe-101-RR-CLL-SLL-1.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BTKi-Switch-Seq-MCL_Choksi_EncPoster_EHA_Final.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Cordoba_EHA2025_Sonro-101-SZ_RR_MCL_oral_v6.1_13June2025.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/MAIC-Zanu-vs-AV-TN-CLL_Munir_Poster_EHA_Submitted.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-309.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-307.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/Naing_ESMO-2025_Poster_HPK1-2G_PRINT-READY.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/HNSCC-201_Kim_Oral_AACR-2026_Final.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-301.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RATIONALE-306.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/CaDAnCe-101-RR-FL-and-MZL.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/RWE-Burden-Tx-Ptns-Outcomes-MCL-Symphony_Alencar_Poster_EHA_Submitted.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/CaDAnCe-101-RR-CLL-SLL.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/CaDAnCe-101-RR-WM.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BTKi-Hypertension-Risk-CLL-Symphony_Ali_Poster_EHA_Final.pdf 2026-05-15T15:07:01+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-1b-initial-results-mrd-guided-therapy-sonrotoclax-plus-obinutuzumab-in-tn-cll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-102-nHL-CLL_Li_Poster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_primary-analysis-phase-2-study-of-sonrotoclax-monotherapy-in-rr-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_real-world-cll-treatment-patterns-with-venetoclax-combination-time-limited-therapy.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_real-world-cll-treatment-patterns-and-age-disparities-in-us.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_symptom-based-progression-free-survival-in-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_sequoia-arm-d-3-year-results-of-zanubrutinib-plus-venetoclax-for-tn-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-1b-initial-results-of-zanubrutinib-plus-obinutuzumab-plus-sonrotoclax-in-tn-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-201-RR-MCL.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-cadance-101-updated-results-of-btk-degrader-bgb-16673-in-rr-wm.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-SZ-RR-CLL.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-24714-101-Biomarker_Zhang_Poster_AACR-2026_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_genetic-marker-testing-impact-on-cll-treatment-selection-and-outcomes.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_long-term-zanubrutinib-data-in-acalabrutinib-intolerant-b-cell-malignancies.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-103-RR-AML_Montesinos_Poster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_ongoing-phase-1b-2-btk-degrader-in-combination-in-rr-b-cell-malignancies.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-cadance-101-btk-degrader-bgb-16673-in-rr-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-3-cadance-304-study-of-btk-degrader-bgb-16673-vs-pirtobrutinib-in-rr-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ALPINE.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_preliminary-phase-1-1b-first-in-human-study-of-bgb-21447-in-nhl-patients.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_real-world-mediators-of-racial-inequities-in-novel-cll-therapy-access-in-us.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-2-rosewood-final-analysis-zanubrutinib-obinutuzumab-in-rr-follicular-lymphoma.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_indirect-comparison-of-efficacy-of-zanubrutinib-vs-ibrutinib-in-rr-mcl.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-sonrotoclax-bgb-11417-monotherapy-in-previously-treated-btk-inhibitor-rr-mcl-patients.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASPEN.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_treatment-patterns-and-outcomes-of-second-gen-btk-inhibitors-in-cll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_real-world-treatment-patterns-over-time-by-patients-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-24714-101-Clinical_Varkaris_Poster_AACR-2026_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-3-alpine-lte1-6-year-long-term-data-of-zanubrutinib-in-rr-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-Mono-RR-CLL_Opat_Poster_EHA_Finalv2.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_canopy-epro-based-rtm-outcomes-during-btki-treatment-in-cll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-3-sequoia-6-year-long-term-data-of-zanubrutinib-vs-br-in-tn-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BG-68501-101.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_prognostic-models-in-patients-treated-with-zanubrutinib-in-rr-cll-post-hoc-analysis.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/1L-Comp-Effect-CLL-Flatiron_Jacobs_EncPoster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-103-TN-AML_Shortt_Poster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-TN-CLL.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_initial-phase-1b-2-sonrotoclax-with-carfilzomib-and-dexamethasone-in-rr-mm-t1114-positive.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-103-RR-AML.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_pfs-in-patients-with-low-hrqol-treated-with-zanubrutinib-vs-ibrutinib-in-rr-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-3111-110-Primary-DLBCL_Song_EncPoster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-103-TN-AML.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-Mono-WM_Cheah_Poster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-3111-206.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-SZ-RR-MCL.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_patient-preferences-and-factors-affecting-patient-treatment-decisions-for-cll-in-japan.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-102.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_real-world-treatment-patterns-and-biomarker-use-in-cll-sll-patients-aged-gte-65-years.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-105.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-RR-CLL.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-1b-bgb-11417-101-study-of-sonrotoclax-plus-zanubrutinib-in-tn-cll-sll_umrd.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_nnt-analysis-of-zanubrutinib-vs-other-covalent-btki-in-high-risk-rr-cll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-105-MM_Dhakal_Poster_EHA_Final.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-2-bgb-3111-218-zanubrutinib-in-cd79b-mutated-rr-dlbcl.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_treatment-patterns-and-outcomes-of-second-gen-btk-inhibitors-in-cll-1.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-cadance-101-updated-results-of-btk-degrader-bgb-16673-in-rr-indolent-nhl.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/BGB-11417-101-SO-TN-CLL.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-3-study-of-sonrotoclax-plus-anti-cd20-vs-venetoclax-plus-rituximab-in-rr-cll-sll.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/05/ASH2025_phase-1-cadance-101-updated-study-results-of-btk-degrader-bgb-16673-in-rr-rt.pdf 2026-05-15T15:07:00+00:00 https://beonemedaffairs.com/us/wp-content/uploads/sites/3/2026/04/Clinical-Pipeline_2026-February-1.pdf 2026-05-15T15:06:59+00:00